ARUP Laboratories

The European Commission’s approval of BioMarin’s novel gene therapy for severe hemophilia A has paved the way for ARUP’s AAV5 DetectCDx™ Kit to become the first ARUP-developed test used in Europe.

Based on data from 21,916 participants in 33 studies, the Association for the Advancement of Blood and Biotherapies (AABB) has issued guidelines for use of convalescent plasma in COVID-19 treatment.

The National Institute of Allergy and Infectious Diseases has awarded Medical Director Allison Carey, MD, PhD, $1.5 million over five years to fund her groundbreaking research.